Canada Pension Plan Investment Board
ATRA icon

Canada Pension Plan Investment Board’s Atara Biotherapeutics ATRA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,160
Closed -$966K – 1258
2022
Q1 		$966K Sell
4,160
-3,120
-43% -$994K ﹤0.01% 846
2021
Q4 		$2.87M Sell
7,280
-440
-6% -$185K ﹤0.01% 812
2021
Q3 		$3.46M Buy
7,720
+4,160
+117% +$1.49M ﹤0.01% 744
2021
Q2 		$1.38M Buy
3,560
+120
+3% +$42.8K ﹤0.01% 825
2021
Q1 		$1.24M Sell
3,440
-11,840
-77% -$5.23M ﹤0.01% 960
2020
Q4 		$7.5M Sell
15,280
-40,002
-72% -$18.5M 0.01% 542
2020
Q3 		$17.9M Sell
55,282
-2,973
-5% -$1.01M 0.03% 299
2020
Q2 		$21.2M Sell
58,255
-13,745
-19% -$3.47M 0.05% 247
2020
Q1 		$15.3M Hold
72,000
– – 0.04% 279
2019
Q4 		$29.6M Buy
72,000
+71,142
+8,292% +$24.5M 0.06% 244
2019
Q3 		$303K Buy
+858
New +$320K ﹤0.01% 1083
2019
Q2 		– Sell
-784
Closed -$779K – 1253
2019
Q1 		$779K Sell
784
-6,900
-90% -$6.41M ﹤0.01% 1130
2018
Q4 		$6.67M Buy
+7,684
New +$7.14M 0.01% 692

Other funds holding ATRA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Canada Pension Plan Investment Board's ATRA Position: Q2 2022 in Review

Canada Pension Plan Investment Board sold out of Atara Biotherapeutics (ATRA) in Q2 2022, closing a stake of 4,160 shares — an estimated $966K sold.

Canada Pension Plan Investment Board first reported a position in ATRA in Q4 2018 and held it in 13 quarters. The position peaked at $29.6M in Q4 2019. 134 funds tracked by Wall St. Rank hold ATRA as of Q2 2022.

  • Canada Pension Plan Investment Board reported no remaining Atara Biotherapeutics position as of Q2 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 4,160 Atara Biotherapeutics shares in Q2 2022, an estimated $966K.
  • Canada Pension Plan Investment Board first reported a position in Atara Biotherapeutics in Q4 2018 and held it in 13 quarters.
  • Canada Pension Plan Investment Board's Atara Biotherapeutics position peaked at $29.6M in Q4 2019.
  • 134 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2022, filed 12 Aug 2022.